Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

China flag China · Delayed Price · Currency is CNY
6.63
+0.02 (0.30%)
At close: Dec 5, 2025
-11.13%
Market Cap 43.79B
Revenue (ttm) 7.95B
Net Income (ttm) 1.83B
Shares Out 6.60B
EPS (ttm) 0.28
PE Ratio 24.10
Forward PE 17.92
Dividend 0.07 (1.00%)
Ex-Dividend Date Jul 14, 2025
Volume 27,393,480
Average Volume 29,697,250
Open 6.60
Previous Close 6.61
Day's Range 6.56 - 6.63
52-Week Range 6.50 - 7.77
Beta 0.38
RSI 41.19
Earnings Date Apr 24, 2026

About SHE:002252

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. The company was founded in 1988 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 3,350
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002252
Full Company Profile

Financial Performance

In 2024, SHE:002252's revenue was 8.18 billion, an increase of 2.67% compared to the previous year's 7.96 billion. Earnings were 2.19 billion, an increase of 23.25%.

Financial Statements

News

There is no news available yet.